The relationship between urinary tract infections and vesicoureteral reflux in Turkish children

Vitamin D deficiency as a risk factor for renal scarring in recurrent urinary tract infections

BACKGROUND

Renal scarring is a serious complication in recurrent urinary tract infections (UTIs). Vitamin D deficiency has also been reported to be a risk factor for UTIs although, to date, no association between vitamin D deficiency and renal scarring has yet been identified. In the present study, it was investigated whether vitamin D deficiency may be a risk factor for renal scarring in patients with recurrent UTIs.

METHODS

The study included patients between the ages of 1 and 18 years who were admitted to the pediatric nephrology department of the center between November 1, 2018 and November 1, 2019 and who were diagnosed with recurrent UTIs. The medical records of the patients were reviewed for the collection of demographic data, vitamin D levels, ultrasonography results and scintigraphic investigations with 99m-technetium dimercaptosuccinic acid (^99m Tc-DMSA). The patients were divided into two groups: those with and without renal scarring, diagnosed via ^99m Tc-DMSA. The vitamin D levels and other parameters of the two groups were compared.

RESULTS

Vitamin D deficiency (<20 ng/mL) was observed in 73.9% of the patients without renal scarring, and in 94.1% of those with renal scarring (P = 0.015). A logistic regression analysis revealed vitamin D deficiency to be an independent risk factor for renal scarring in patients with recurrent UTIs (OR = 0.796 [0.691-0.917]).

CONCLUSIONS

Vitamin D deficiency is found to be a risk factor for renal scarring in patients with recurrent UTIs. Vitamin D treatment may contribute to the prevention of renal scarring in patients with recurrent UTI.

Usefulness of the classification of urinary dysfunction for the prognosis of the first endoscopic treatment of vesicoureteral reflux in children over the age of 3

OBJECTIVES

To assess the diagnostic performance of urinary dysfunction patterns associated with vesicoureteral reflux (VUR) in children over the age of 3 according to the result of the first endoscopic treatment (ENDT1), grouped into a classification designed by our group (CMD.URI-La Fe). Comparison with other current classifications such as that of Van Batavia et al. MATERIAL AND METHODS: Ambispective cross-cutting study of a sample of 50 children.

EXCLUSION CRITERIA

previous ENDT, age ≤ 3 years, anatomical or neurological anomalies and a history of ureteral or abdominopelvic surgery. Prior to the ENDT1, a bladder voiding function assessment by uroflowmetry+electromyography (UF-EMG) and post-mictional residue (ultrasound). Other variables from the bladder diary, pre-mictional bladder wall thickness and other clinical variables. The correction of VUR was assessed by isotope cystography 3 months after the treatment. Urinary patterns were classified according to the significant variables (URI-La Fe), and the diagnostic performance of this classification was assessed, comparing it to the classification of patients as proposed by Van Batavia et al. RESULTS: Mean age: 6.8±2.28 years. Males/females (44%/56%). Grades of VUR (mild/moderate/severe). ENDT1 VUR correction rate: 77% (n=38). Diagnostic performance (Van Batavia; URI-La Fe): correct prediction (37.5%; 75%), sensitivity (32.4%; 87.8%), specificity (54.5%; 46.6%), positive predictive value (70.6; 78.3%) and negative predictive value (19.4%; 63.6%).

CONCLUSIONS

Our results show the usefulness of the non-invasive test and the classification of urinary dysfunction in children aged over 3 years prior to the first endoscopic treatment of VUR.

Predictors of abnormal renal cortical scintigraphy in children with first urinary tract infection: the importance of time factor

INTRODUCTION

We evaluated different factors predicting the development of acute pyelonephritis in Iranian children, with special attention to time factor.

METHODS

One hundred nineteen patients (93 females and 26 males; age = 32.6 ± 30.8 months) with first urinary tract infection (UTI) were evaluated. None had previous urological problems. Prior to antibiotic therapy blood samples were gathered for laboratory evaluation. Vital signs on admission were measured. Clinical and laboratory indices, including therapeutic delay time (TDT) and therapeutic response time (TRT), were measured. Most patients were evaluated with renal ultrasound in the first three days following admission. All patients underwent dimercaptosuccinic acid (DMSA) renal scintigraphy and 71 were assessed for vesicoureteral reflux (VUR).

RESULTS

DMSA scans were abnormal in 77 cases, of which 11 cases had bilateral renal involvement. Mean values for TDT, TRT, leukocyte count (LC), absolute neutrophil count (ANC), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) were 74.1 h, 39.6 h, 15725 ± 6682 mm(-3), 10772 ± 6458 mm(-3), 51.9 ± 32.5 mm, and 27.3 ± 25.1 mg l(-1), respectively. VUR was present in 29 of 142 evaluated renal units.

CONCLUSION

TDT ≥ 48 h, TRT ≥ 24 h, axillary temperature ≥ 39°C, LC ≥ 13500 mm(-3), and age ≥ 18 months predicted abnormal DMSA scan in patients with first episode of UTI. Considerably higher TDT and TRT values of the current study compared to previous ones suggests the more important role of time factor in predicting abnormal DMSA findings in a developing country than in developed ones.

Controversies in the management of vesicoureteral reflux: the rationale for the RIVUR study

The current management of vesicoureteral reflux (VUR) focuses on the prevention of urinary tract infections (UTI), with curative surgery being limited to those children that fail conservative measures. This is based on the assumption that UTIs are preventable with the use of prophylatic antibiotics, leading to reduction of renal scarring, and the possibility that VUR in children can resolve spontaneously.

METHODS

Review of the recent literature has demonstrated a growing concern that antibiotic prophylaxis may not lead to prevention of UTIs. Additionally, data indicate that renal scarring may not be preventable with antibiotic prophylaxis or even surgical correction of VUR. An overview of all of the current controversies is presented in this paper.

RESULTS

Does antibiotic prophylaxis lead to reduction in UTIs in children with VUR? To address this question, the National Institutes of Health have developed a randomized placebo-controlled study of children with VUR (the RIVUR Study), identified following the development of a UTI.

CONCLUSIONS

There are far reaching consequences of the results of the RIVUR Study. If antibiotic prophylaxis does not prevent UTI in children with VUR, or lead to reduction in renal scarring, does identification of VUR provide any benefits? Perhaps appropriate treatment of UTI may be all that is necessary for preserving renal function. Final answers will have to wait until the completion of this study.